CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

Clinical trial NCT05685602 · SUSPENDED

Trial details

NCT number: NCT05685602
Sponsor: National Cancer Institute (NCI)
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Ductal Adenocarcinoma Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Unresectable Pancreatic Ductal Adenocarcinoma

Start date: 2023-06-12
Primary completion: 2027-04-30
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.